Identifying Tumor-Suppressive Genes in Breast Cancer
Author Information
Author(s): Mitsueda Reiko, Nagata Ayako, Toda Hiroko, Tomioka Yuya, Yasudome Ryutaro, Kato Mayuko, Shinden Yoshiaki, Nakajo Akihiro, Seki Naohiko, Falzone Luca, Calina Daniela, Gattuso Giuseppe
Primary Institution: Kagoshima University
Hypothesis
miR-30a-3p acts as a tumor-suppressive miRNA in breast cancer cells.
Conclusion
The study found that miR-30a-3p suppresses aggressive phenotypes in breast cancer cells and identifies ANLN as a therapeutic target.
Supporting Evidence
- miR-30a-3p was significantly downregulated in breast cancer tissues.
- Ectopic expression of miR-30a-3p suppressed cancer cell proliferation, migration, and invasion.
- Four genes (ANLN, CCNB1, BIRC5, and KIF23) were identified as potential therapeutic targets.
- High expression of ANLN correlated with poorer overall survival in breast cancer patients.
Takeaway
This study shows that a tiny molecule called miR-30a-3p can help stop breast cancer cells from growing and spreading by controlling certain genes.
Methodology
The study used RNA sequencing and ectopic expression assays in breast cancer cell lines to analyze the effects of miR-30a-3p.
Participant Demographics
Breast cancer clinical specimens from the TCGA database.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website